CLVS Stock Recent News

Short Squeeze Penny Stocks To Watch The post Penny Stocks To Buy: 3 Short Squeeze Stocks To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Source: rafapress / Shutterstock.com Clovis Oncology (NASDAQ: CLVS ) stock is rising higher on Monday following the release of results from a Phase 3 clinical trial. That trail covers Rubraca as a monotherapy for the treatment of ovarian cancer.

Clovis (CLVS) reported earnings 30 days ago. What's next for the stock?

Clovis (CLVS) incurs a wider-than-estimated loss in second-quarter 2022. Sales of the sole marketed drug Rubraca decline year over year due to COVID-19 impacts.

The biotech's Q2 financial results are concerning investors today.

Clovis Oncology (NASDAQ: CLVS ) stock is down more than 10% today after posting its second-quarter financial results. The biopharmaceutical company missed on revenue and profits, leading the way for today's selloff.

Clovis Oncology, Inc. (NASDAQ:CLVS ) Q2 2022 Earnings Conference Call August 8, 2022 8:30 AM ET Company Participants Anna Sussman - VP, IR Patrick Mahaffy - Co-Founder, CEO, President & Executive Director Lindsey Rolfe - EVP, Clinical Development & Pharmacovigilance and Chief Medical Officer Daniel Muehl - EVP & CFO Conference Call Participants Operator Good morning. My name is Samantha, and I will be your conference operator today.

BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--First paragraph, second sentence of release should read: Clovis' senior management will host a conference call and live audio webcast at 8:30am ET to discuss Clovis' results and business outlook in greater detail. (instead of Clovis' senior management will host a conference call and live audio webcast at 6:30am ET to discuss Clovis' results and business outlook in greater detail.). The updated release reads: CLOVIS ONCOLOGY TO ANNOUNCE SECOND QUARTER 2022 FINANC

BOULDER, Colo.--(BUSINESS WIRE)---- $CLVS--Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2022 financial results and provide an update on its clinical development programs and regulatory and business outlook on Monday, August 8, 2022, before the open of the US financial markets. Clovis' senior management will host a conference call and live audio webcast at 6:30am ET to discuss Clovis' results and business outlook in greater detail. The conference call will be simultaneously webcas

Investors were cheered by news of a freshly signed supply deal.